Compare Ovintiv Inc. (DE) (OVV) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ovintiv Inc. (DE) vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Ovintiv Inc. (DE) trades at $63.88 (market cap $17.53B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.93 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is the larger of the two by market cap, and Ovintiv Inc. (DE) pays the higher dividend (1.89%). Which is the better fit depends on your goals — on Pluang, investors hold Ovintiv Inc. (DE) for 1 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| OVV | RPRX | |
|---|---|---|
Market Cap | $17.53B | $25.27B |
Volume | 3,002,714 | 3,671,183 |
Sector | Energy | Health |
52-Week High | $66.97 | $63.96 |
52-Week Low | $35.97 | $35.44 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $21.86B | $32.50B |
Dividend Yield | 1.89% | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ovintiv Inc. (DE)
Ovintiv explores for and produces oil and natural gas in North America. Its operations are concentrated in major U.S. and Canadian resource basins.
Read more on OVV →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
